Table 2 Demographic and clinical characteristics of the patients all patients
Characteristic | Total (N = 105) N (%) | Alive (N = 78) N (%) | Deceased (N = 27) N (%) | p-value |
|---|---|---|---|---|
Male | 86 (81.9) | 63 (80.8) | 23 (85.2) | 0.601 |
White | 88 (83.8) | 66 (84.6) | 22 (81.5) | 0.706 |
Primary Site | 0.052 | |||
Larynx | 38 (36.2) | 24 (30.8) | 14 (51.9) | |
Pharynx | 67 (63.8) | 54 (69.2) | 13 (48.1) | |
T-Stage | 0.630 | |||
I-II | 43 (41.0) | 33 (42.3) | 10 (37.0) | |
III-IV | 62 (59.0) | 45 (57.7) | 17 (63.0) | |
N-Stage | 0.035 | |||
0–1 | 45 (42.9) | 38 (48.7) | 7 (25.9) | |
2–3 | 60 (57.1) | 40 (51.3) | 20 (74.1) | |
Surgery dissection (primary site) | 14 (13.3) | 7 (9.0) | 7 (25.9) | 0.035 |
Cell differentiationa | 0.486 | |||
Poorly | 35 (38.5) | 26 (39.4) | 9 (36.0) | |
Moderately | 48 (52.7) | 33 (50.0) | 15 (60.0) | |
Well | 8 (8.8) | 7 (10.6) | 1 (4.0) | |
Best overall responseb | < 0.001 | |||
Progressive disease | 4 (4.3) | 1 (1.4) | 3 (13.6) | |
Stable disease | 22 (23.4) | 12 (16.7) | 10 (45.5) | |
Partial response | 32 (34.0) | 25 (34.7) | 7 (31.8) | |
Complete response | 36 (38.3) | 34 (47.2) | 2 (9.1) | |
Weight lossc (previous 6 months) | 0.036 | |||
> 10% body weight | 12 (12.2) | 5 (6.9) | 7 (26.9) | |
5–10% body weight | 18 (18.4) | 15 (20.8) | 3 (11.5) | |
< 5% body weight | 68 (69.4) | 52 (72.2) | 16 (61.5) | |
Mean (SD) | Mean (SD) | Mean (SD) | ||
Age | 58.9 (10.7) | 57.5 (9.8) | 62.6 (12.4) | 0.034 |